Journal
TRANSLATIONAL RESEARCH
Volume 161, Issue 4, Pages 307-312Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2012.12.016
Keywords
-
Categories
Funding
- Hemophilia Consortium
- Fanconi Anemia Research Fund
Ask authors/readers for more resources
Genetic correction of hemophilia A and B was long considered amenable to the available gene transfer technologies. This assumption has come to fruition with the recent results of a phase I/II trial for hemophilia B. Here we review the clinical application of gene therapy for the hemophilia's as a paradigm of the evolution of gene transfer science and technology. This review is not intended as comprehensive but rather to highlight current clinical developments of gene therapy for the hemophilias. (Translational Research 2013;161:307-312)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available